Dynorphin (1-8) inhibits stimulated release of oxytocin but not vasopressin from isolated neurosecretory endings of the rat neurohypophysis

Neuropeptides. 1988 May-Jun;11(4):163-7. doi: 10.1016/0143-4179(88)90070-4.

Abstract

The effects of the opioid peptide dynorphin (1-8) on oxytocin and vasopressin release at the level of isolated neurosecretory endings were investigated. Neurosecretory endings prepared by homogenization and centrifugation were placed on a filter and constantly superfused. Stimulated hormone release was evoked by potassium depolarization (30 mM) and simultaneous increase of the osmolarity (20 mosmol/1). Stimulation resulted in two peaks of hormone release--a short first peak and a longer second one. Addition of dynorphin (1-8) (10(-7) M) to the superfusion buffer significantly diminished the first peak of oxytocin release and totally abolished the second. There was no effect of dynorphin (1-8) on vasopressin release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dynorphins / pharmacology*
  • In Vitro Techniques
  • Male
  • Neurosecretory Systems / drug effects
  • Oxytocin / metabolism*
  • Peptide Fragments / pharmacology*
  • Pituitary Gland, Posterior / drug effects*
  • Pituitary Gland, Posterior / metabolism
  • Rats
  • Rats, Inbred Strains
  • Vasopressins / metabolism*

Substances

  • Peptide Fragments
  • Vasopressins
  • Oxytocin
  • Dynorphins
  • dynorphin (1-8)